The relationship between plasminogen activator inhibitor-1 and proinflammatory and counterinflammatory mediators in children with meningococcal septic shock

Journal of Infectious Diseases

Volumn 173, Issue 5, 1996, Pages 1148-1156

  Kornelisse, René F ^b   Hazelzet, Jan A ^b   Savelkoul, Huub F J ^b   Hop, Wim C J ^b   Suur, Marja H ^b   Borsboom, Alexander N J ^b   Risseeuvv Appel, Inge M ^b   Van Der Voort, Edwin D ^b   De Groot, Ronald ^a  

^a SOPHIA CHILDREN S HOSPITAL   (Netherlands)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; INTERLEUKIN 10; INTERLEUKIN 6; INTERLEUKIN 8; PLASMINOGEN ACTIVATOR INHIBITOR 1; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR RECEPTOR;

ADOLESCENT; ARTICLE; CHILD; CLINICAL ARTICLE; FATALITY; FEMALE; HEMOSTASIS; HUMAN; INFANT; MALE; MENINGOCOCCOSIS; PETECHIA; PRIORITY JOURNAL; SEPTIC SHOCK;

EID: 0029898454     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1093/infdis/173.5.1148     Document Type: Article

References (15)

1. van Deuren M, Santman FW, van Dalen R, Sauerwein RW, Span LF, van der Meer JW. Plasma and whole blood exchange in meningococcal sepsis. Clin Infect Dis 1992;15:424-30.
2. Thomson AP, Sills JA, Hart CA. Validation of the Glasgow meningococcal septicemia prognostic score: a 10-year retrospective survey. Crit Care Med 1991;19:26-30.
3. Brandtzaeg P, Kierulf P, Gaustad P, et al. Plasma endotoxin as a predictor of multiple organ failure and death in systemic meningococcal disease. J Infect Dis 1989;159:195-204.
4. Girardin E, Grau GE, Dayer JM, Roux-Lombard P, Lambert PH. Tumor necrosis factor and interleukin-1 in the serum of children with severe infectious purpura. N Engl J Med 1988;319:397-400.
5. Halstensen A, Pedersen SH, Haneberg B, Bjorvatn B, Solberg CO. Case fatality of meningococcal disease in western Norway. Scand J Infect Dis 1987;19:35-42.
6. Leclerc F, Beuscart R, Guillois B, et al. Prognostic factors of severe infectious purpura in children. Intensive Care Med 1985;11:140-3.
7. Bone RC. Modulators of coagulation. A critical appraisal of their role in sepsis. Arch Intern Med 1992;152:1381-9.
8. van der Poll T, van Deventer SJ, Hack CE, et al. Effects on leukocytes after injection of tumor necrosis factor into healthy humans. Blood 1992;79:693-8.
9. van der Poll T, van Deventer SJ, Buller HR, Sturk A, ten Gate JW. Comparison of the early dynamics of systemic prostacyclin release after administration of tumor necrosis factor and endotoxin to healthy humans. J Infect Dis 1991;164:599-601.
10. van Deventer SJ, Buller HR, ten Cate JW, Aarden LA, Hack CE, Sturk A. Experimental endotoxemia in humans: analysis of cytokine release and coagulation, fibrinolytic, and complement pathways. Blood 1990;76:2520-6.
11. Brandtzaeg P, Mollnes TE, Kierulf P. Complement activation and endotoxin levels in systemic meningococcal disease. J Infect Dis 1989;160:58-65.
12. de Waal Malefyt R, Abrams J, Bennett B, Figdor CG, de Vries JE. Interleukin 10 (IL-10) inhibits cytokine synthesis by human monocytes: an autoregulatory role of IL-10 produced by monocytes. J Exp Med 1991;174:1209-20.
13. Dembic Z, Loetscher H, Gubler U, et al. Two human TNF receptors have similar extracellular, but distinct intracellular, domain sequences. Cytokine 1990;2:231-7.
14. Kohno T, Brewer MT, Baker SL, et al. A second tumor necrosis factor receptor gene product can shed a naturally occurring tumor necrosis factor inhibitor. Proc Natl Acad Sci USA 1990;87:8331-5.
15. Lantz M, Gullberg U, Nilsson E, Olsson I. Characterization in vitro of a human tumor necrosis factor-binding protein. A soluble form of a tumor necrosis factor receptor. J Clin Invest 1990;86:1396-42.